Promoting HPV Vaccination Among Young Adults in Texas
This clinical trial studies how to improve the human papillomavirus (HPV) vaccination rate in young adults in Texas. This trial aims to learn more about how researchers and health care providers can increase HPV vaccination among college students.
Conditions:
🦠 Human Papillomavirus Infection
🗓️ Study Start (Actual) 26 July 2021
🗓️ Primary Completion (Estimated) 31 July 2026
✅ Study Completion (Estimated) 31 July 2026
👥 Enrollment (Estimated) 1200
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Houston, Texas, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Age 18-26 years. This criterion is based on the CDC recommendation of vaccination up to 26 years of age and the fact that individuals 18 years and older can consent by themselves for on-site vaccination
    • * Ability to read and understand English
    • * Self-identification as not yet having received any HPV vaccine injections. Self-identification is justified because it is safe to be vaccinated again, which could happen if a previously vaccinated person forgets their vaccination. Furthermore, in a person previously vaccinated with an older version of the vaccine, which targeted fewer HPV types, receiving the newer version would be advantageous and not cause any harm. Alternatives to self-identification, such as obtaining medical records from doctors' offices, would be very challenging for young adults, especially for those who do not remember when and where they might have received vaccination
    • * Access to a smart phone, tablet or computer that is connected to the internet
    • * Current enrollment in one of the participating schools with an anticipated continuous enrollment of at least 9 months

    Exclusion Criteria:

    • * Being pregnant
    • * Having a life-threatening allergy to any component of the HPV vaccine
Ages Eligible for Study: 18 Years to 26 Years (ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 25 August 2021
  • First Submitted that Met QC Criteria 15 September 2021
  • First Posted 27 September 2021

Study Record Updates

  • Last Update Submitted that Met QC Criteria 24 July 2024
  • Last Update Posted 26 July 2024
  • Last Verified July 2024